169 related articles for article (PubMed ID: 36515930)
1. Relationship Between Preprocedural Lipid Levels and Periprocedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.
Maadani M; Sarraf NS; Alilou S; Aeinfar K; Sadeghipour P; Zahedmehr A; Fathollahi MS; Hashemi Ghadi SI; Zavarehee A; Zolfaghari M; Zolfaghari R
Tex Heart Inst J; 2022 Nov; 49(6):. PubMed ID: 36515930
[TBL] [Abstract][Full Text] [Related]
2. Relationship of high-density lipoprotein cholesterol with periprocedural myocardial injury following elective percutaneous coronary intervention in patients with low-density lipoprotein cholesterol below 70 mg/dL.
Li XL; Guo YL; Zhu CG; Xu RX; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL; Li JJ
J Am Heart Assoc; 2015 Jan; 4(1):e001412. PubMed ID: 25572484
[TBL] [Abstract][Full Text] [Related]
3. Association of preprocedural low-density lipoprotein cholesterol levels with myocardial injury after elective percutaneous coronary intervention.
Li XL; Li JJ; Guo YL; Zhu CG; Xu RX; Li S; Qing P; Wu NQ; Jiang LX; Xu B; Gao RL
J Clin Lipidol; 2014; 8(4):423-32. PubMed ID: 25110224
[TBL] [Abstract][Full Text] [Related]
4. Relationship Between Preoperative Low-Density Lipoprotein Cholesterol and Periprocedural Myocardial Injury in Patients Following Elective Percutaneous Coronary Intervention in Southern China.
Zhong Z; Liu J; Zhang Q; Zhong W; Li B; Li C; Liu Z; Yang M; Zhao P
Med Sci Monit; 2018 Jun; 24():4154-4161. PubMed ID: 29910459
[TBL] [Abstract][Full Text] [Related]
5. Elective percutaneous coronary intervention: the relationship between preprocedural blood glucose levels and periprocedural myocardial injury.
Madani M; Alizadeh K; Ghazaee SP; Zavarehee A; Abdi S; Shakerian F; Salehi N; Firouzi A
Tex Heart Inst J; 2013; 40(4):410-7. PubMed ID: 24082370
[TBL] [Abstract][Full Text] [Related]
6. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
[TBL] [Abstract][Full Text] [Related]
7. Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention.
Kini AS; Motoyama S; Vengrenyuk Y; Feig JE; Pena J; Baber U; Bhat AM; Moreno P; Kovacic JC; Narula J; Sharma SK
JACC Cardiovasc Interv; 2015 Jun; 8(7):937-45. PubMed ID: 26088511
[TBL] [Abstract][Full Text] [Related]
8. Impact of Periprocedural Myocardial Injury and Infarction Definitions on Long-Term Mortality After Chronic Total Occlusion Percutaneous Coronary Intervention.
Song L; Wang Y; Guan C; Zou T; Sun Z; Xie L; Zhang R; Dou K; Yang W; Wu Y; Qiao S; Xu B
Circ Cardiovasc Interv; 2021 Nov; 14(11):e010923. PubMed ID: 34674557
[TBL] [Abstract][Full Text] [Related]
9. Incidence, predictors and clinical significance of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Ma J; Chen A; Lu D; Wu Y; Ren D; Zhang C; Dai C; Zhang Y; Qian J; Ge J
J Cardiol; 2020 Sep; 76(3):309-316. PubMed ID: 32354492
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum miR-133a predicts patients at risk of periprocedural myocardial injury after elective percutaneous coronary intervention.
Zhou Y; Chen Z; Chen A; Ma J; Qian J; Ge J
Cardiol J; 2022; 29(2):284-292. PubMed ID: 32207842
[TBL] [Abstract][Full Text] [Related]
11. Association between the magnitude of periprocedural myocardial injury and prognosis in patients undergoing elective percutaneous coronary intervention.
Zhou Y; Chen Z; Chen A; Ma J; Dai C; Lu D; Wu Y; Li S; Chen J; Liu M; Li C; Lu H; Qian J; Ge J
Eur Heart J Qual Care Clin Outcomes; 2022 Nov; 8(8):871-880. PubMed ID: 34962992
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Impact of Periprocedural Myocardial Infarction in Patients Undergoing Elective Percutaneous Coronary Interventions.
Koskinas KC; Ndrepepa G; Räber L; Karagiannis A; Kufner S; Zanchin T; Hieber J; Hunziker L; Mayer K; Byrne RA; Heg D; Windecker S; Kastrati A
Circ Cardiovasc Interv; 2018 Dec; 11(12):e006752. PubMed ID: 30545257
[TBL] [Abstract][Full Text] [Related]
13. Relationship between Pre-Procedural Serum Lipid Profile and Post-Procedural Myocardial Injury in Patients Undergoing Elective Percutaneous Coronary Intervention.
Maadani M; Abdi S; Parchami-Ghazaee S; Alizadeh K; Fathi H; Musavi R
Res Cardiovasc Med; 2013 Nov; 2(4):169-73. PubMed ID: 25478516
[TBL] [Abstract][Full Text] [Related]
14. Impact of increased admission lipid levels on periprocedural myocardial injury following an elective percutaneous coronary intervention.
Buturak A; Degirmencioglu A; Erturk M; Karakurt H; Demir AR; Surgit O; Pusuroglu H; Akgul O; Serteser M; Norgaz T; Gorgulu S
Coron Artery Dis; 2015 Jun; 26(4):333-40. PubMed ID: 25714068
[TBL] [Abstract][Full Text] [Related]
15. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a Consensus Document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Bulluck H; Paradies V; Barbato E; Baumbach A; Bøtker HE; Capodanno D; De Caterina R; Cavallini C; Davidson SM; Feldman DN; Ferdinandy P; Gili S; Gyöngyösi M; Kunadian V; Ooi SY; Madonna R; Marber M; Mehran R; Ndrepepa G; Perrino C; Schüpke S; Silvain J; Sluijter JPG; Tarantini G; Toth GG; Van Laake LW; von Birgelen C; Zeitouni M; Jaffe AS; Thygesen K; Hausenloy DJ
Eur Heart J; 2021 Jul; 42(27):2630-2642. PubMed ID: 34059914
[TBL] [Abstract][Full Text] [Related]
16. Remnant cholesterol predicts periprocedural myocardial injury following percutaneous coronary intervention in poorly-controlled type 2 diabetes.
Zeng RX; Li S; Zhang MZ; Li XL; Zhu CG; Guo YL; Zhang Y; Li JJ
J Cardiol; 2017 Aug; 70(2):113-120. PubMed ID: 28209463
[TBL] [Abstract][Full Text] [Related]
17. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging.
Selvanayagam JB; Porto I; Channon K; Petersen SE; Francis JM; Neubauer S; Banning AP
Circulation; 2005 Mar; 111(8):1027-32. PubMed ID: 15723982
[TBL] [Abstract][Full Text] [Related]
18. Relationship between subclinical cardiac troponin I elevation and culprit lesion characteristics assessed by optical coherence tomography in patients undergoing elective percutaneous coronary intervention.
Lee T; Murai T; Yonetsu T; Suzuki A; Hishikari K; Kanaji Y; Matsuda J; Araki M; Niida T; Isobe M; Kakuta T
Circ Cardiovasc Interv; 2015 Apr; 8(4):. PubMed ID: 25829198
[TBL] [Abstract][Full Text] [Related]
19. Periprocedural myocardial damage during percutaneous coronary intervention: a point-of-care platelet testing and intravascular ultrasound/virtual histology study.
Michalak M; Huczek Z; Filipiak KJ; Roik MF; Kochman J; Opolski G
Kardiol Pol; 2013; 71(4):325-33. PubMed ID: 23788337
[TBL] [Abstract][Full Text] [Related]
20. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
